Description
PT-141, also known as bremelanotide, is a synthetic cyclic peptide derived from the melanocortin peptide family. Its cyclic configuration distinguishes it from many linear research peptides and contributes to the characteristic PT 141 peptide structure used in melanocortin receptor studies. PubChem identifies bremelanotide as an oligopeptide with a molecular weight of approximately 1,025 Da.
The PT 141 peptide research field focuses largely on melanocortin receptor signaling and the cellular responses associated with this receptor system. Researchers may also examine receptor selectivity, peptide stability, molecular interactions, and signaling behavior under controlled laboratory conditions. The reported PT 141 half-life can vary according to formulation and experimental conditions, so stability and pharmacokinetic measurements should be interpreted within the specific study design rather than treated as universal values.
Features
- Composition: Synthetic cyclic melanocortin peptide
- Alternative Name: Bremelanotide
- Research Code: PT-141
- Molecular Formula: C50H68N14O10
- Molecular Weight: Approximately 1,025 Da
- Structural Characteristic: Cyclic peptide configuration
- Research Focus: Melanocortin receptor activity, receptor signaling, peptide stability, and molecular interactions
- Format: Supplied as lyophilized research material
- Recommended Storage: −20 °C unless otherwise specified in batch documentation
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.
Reviews
There are no reviews yet.